What makes the Future Forward program different from other events you may attend is that it's intensively interactive. There are no plodding "how to" tutorials, no pre-fab company pitches. Every program is designed to blow by the obvious and arrive at real insight -- some of it served up in an intimate workshop format and some of it, at the retreat, served up by the presenters and moderators onstage, with contributions by the movers-and-shakers in our audience. Future Forward is unique in that most of the people in the audience are regular speakers at other conferences; they participate in Future Forward to be among peers.
Past Advisors to Future Forward have included: Elizabeth Altman - Doctoral Student, Harvard Business School; former Vice President, Business Development, Motorola Mobile Devices; David Beisel - Partner, NextView Ventures; Joe Caruso - President, Bantam Group; Gregg Favalora - CTO, VisionScope Technologies, LLC; Shayne Gilbert - Founder, Silverweave; author, 90 Days to Launch; Christopher Herot - CEO, SBR Health; Eric Hjerpe - Partner, Kepha Partners; Scott Kirsner - Innovation Economy columnist, The Boston Globe; Alyssa Stern - Vice President, Future Forward Events, LLC.
Future Forward is one of three high-level programs produced by Future Forward Events, LLC. The other two conferences are:
Launched in 2000, the Nantucket Conference is an annual invitation-only gathering of entrepreneurs, executives and investors, with a distinct East Coast emphasis. Speakers have included founders and CEOs of iRobot, Shutterstock, Zipcar, Etsy, TripAdvisor, Misfit, Indiegogo, Oracle, Google, 3Com, Craigslist, Staples, Akamai, and LogMeIn. More information...
Launched in 2004, the Convergence Forum brings together high-level healthcare players to discuss and debate the most pressing topics of interest to the industry - topics like forging strong corporate partnerships; attracting funding from private and public sources; building successful research organizations; streamlining product development and approval; understanding the coming convergence of biology, software, and medical devices; and staying ahead of regulatory and reimbursement status quo.
Speakers have included CEOs and senior executives from Sanofi Genzyme, Biogen Idec, GlaxoSmithKline, Pfizer, Alnylam Pharmaceuticals, Boston Scientific, Shire, Novartis, and ABIOMED, as well as academic researchers from Harvard, MIT, Tufts, and the Broad Institute. More information...